Authors:
SPIRO TP
ODAY DG
BARDENSTEIN D
COOPER BW
LAZARUS HM
Citation: Tp. Spiro et al., SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE OF CONJUNCTIVAE AFTER ALLOGENEIC BLOOD PROGENITOR-CELL INFUSION, Bone marrow transplantation, 17(6), 1996, pp. 1179-1180
Authors:
IQBAL M
CREGER RJ
FOX RM
COOPER BW
JACOBS G
STELLATO TA
LAZARUS HM
Citation: M. Iqbal et al., LAPAROSCOPIC LIVER-BIOPSY TO EVALUATE HEPATIC-DYSFUNCTION IN PATIENTSWITH HEMATOLOGIC MALIGNANCIES - A USEFUL TOOL TO EFFECT CHANGES IN MANAGEMENT, Bone marrow transplantation, 17(4), 1996, pp. 655-662
Citation: Hm. Lazarus et Ad. Elias, AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTS IN SMALL-CELL LUNG-CANCER, Bone marrow transplantation, 17(1), 1996, pp. 1-3
Authors:
TAHSILDAR HI
REMLER BF
CREGER RJ
COOPER BW
SNODGRASS SM
TARR RW
LAZARUS HM
Citation: Hi. Tahsildar et al., DELAYED, TRANSIENT ENCEPHALOPATHY AFTER MARROW TRANSPLANTATION - CASE-REPORTS AND MRI FINDINGS IN 4 PATIENTS, Journal of neuro-oncology, 27(3), 1996, pp. 241-250
Citation: S. Kaur et al., INCIDENCE AND OUTCOME OF OVERT GASTROINTESTINAL-BLEEDING IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION, Digestive diseases and sciences, 41(3), 1996, pp. 598-603
Citation: Mtf. Espinosa et al., MICROBIOLOGIC CONTAMINATION OF PERIPHERAL-BLOOD PROGENITOR CELLS COLLECTED FOR HEMATOPOIETIC-CELL TRANSPLANTATION, Transfusion, 36(9), 1996, pp. 789-793
Authors:
SCHENKEIN DP
ROITMAN D
MILLER KB
MORELLI J
STADTMAUER E
PECORA AL
CASSILETH P
LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION ASINITIAL THERAPY FOR HIGH-RISK NON-HODGKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 88(10), 1996, pp. 462-462
Authors:
MOSS TJ
COOPER B
KENNEDY MJ
MEAGHER R
PECORA AL
HERZIG RM
UMIEL T
COPELAN E
AKARD L
JANSEN J
CARRUM G
LAZARUS HM
Citation: Tj. Moss et al., THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE IV BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY, Blood, 88(10), 1996, pp. 500-500
Authors:
LAYTON TJ
OSTRANDER AB
SHEA T
LAZARUS HM
BROWN R
DIPERSIO J
ROSS AA
Citation: Tj. Layton et al., USE OF NESTED PCR FOR DETECTION OF T(14-18)-POSITIVE CELLS FOLLOWING CD34-HODGKINS-LYMPHOMA PATIENTS( SELECTION IN SAMPLES FROM NON), Blood, 88(10), 1996, pp. 1499-1499
Citation: Hm. Lazarus, AN ALTERNATIVE TECHNIQUE TO CREATE THE PNEUMOPERITONEUM FOR LAPAROSCOPIC SURGERY, Surgical laparoscopy & endoscopy, 5(3), 1995, pp. 205-208
Authors:
KUTTAH L
WEBER F
CREGER RJ
FOX RM
COOPER BW
JACOBS G
LAZARUS HM
Citation: L. Kuttah et al., ACUTE CHOLECYSTITIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA, Annals of oncology, 6(3), 1995, pp. 302-304
Authors:
GORDON LI
BROWN SG
TALLMAN MS
RADEMAKER AW
WEITZMAN SA
LAZARUS HM
KELLEY CH
MANGAN C
RUBIN H
FOX RM
CREGER RJ
WINTER JN
Citation: Li. Gordon et al., SEQUENTIAL-CHANGES IN SERUM IRON AND FERRITIN IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND RADIATION WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - POSSIBLE IMPLICATIONS FOR TREATMENT RELATED TOXICITY, Free radical biology & medicine, 18(3), 1995, pp. 383-389
Authors:
FIELDS KK
ELFENBEIN GJ
LAZARUS HM
COOPER BW
PERKINS JB
CREGER RJ
BALLESTER OF
HIEMENZ JH
JANSSEN WE
ZORSKY PE
Citation: Kk. Fields et al., MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE, Journal of clinical oncology, 13(2), 1995, pp. 323-332
Authors:
LAWRENCE JB
YOMTOVIAN RA
DILLMAN C
MASARIK SR
CHONGKOLWATANA V
CREGER RJ
MANKA A
HAMMONS T
LAZARUS HM
Citation: Jb. Lawrence et al., RELIABILITY OF AUTOMATED PLATELET COUNTS - COMPARISON WITH MANUAL METHOD AND UTILITY FOR PREDICTION OF CLINICAL BLEEDING, American journal of hematology, 48(4), 1995, pp. 244-250
Authors:
LAZARUS HM
HAYNESWORTH SE
GERSON SL
ROSENTHAL NS
CAPLAN AI
Citation: Hm. Lazarus et al., EX-VIVO EXPANSION AND SUBSEQUENT INFUSION OF HUMAN BONE-MARROW-DERIVED STROMAL PROGENITOR CELLS (MESENCHYMAL PROGENITOR CELLS) - IMPLICATIONS FOR THERAPEUTIC USE, Bone marrow transplantation, 16(4), 1995, pp. 557-564
Authors:
LAZARUS HM
WINTON EF
WILLIAMS SF
GRINBLATT D
CAMPION M
COOPER BW
GUNN H
MANFREDA S
ISAACS RE
Citation: Hm. Lazarus et al., PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER, Bone marrow transplantation, 15(6), 1995, pp. 935-942
Authors:
PRINCE GM
NGUYEN M
LAZARUS HM
BRODSKY RA
TERSTAPPEN LWMM
MEDOF ME
Citation: Gm. Prince et al., PERIPHERAL-BLOOD HARVEST OF UNAFFECTED CD34(-) HEMATOPOIETIC PRECURSORS IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA() CD38(), Blood, 86(9), 1995, pp. 3381-3386
Authors:
KOC ON
GERSON SL
FOX RM
SCHUPP JE
MARKO DA
STECKLEY JA
LAZARUS HM
Citation: On. Koc et al., INFUSION OF CD34 ENRICHED PERIPHERAL-BLOOD PROGENITOR CELLS RESULT INRAPID ENGRAFTMENT AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH ADVANCED LYMPHOMA, Blood, 86(10), 1995, pp. 917-917
Authors:
WINTER IN
LAZARUS HM
RADEMAKER AF
BAUMAN A
COOPER B
THOMAS R
GORDON LI
TALLMAN MS
RUBIN H
GERSON S
MILLER LL
Citation: In. Winter et al., COMPARISON OF PIXY321 AND GM-CSF FOR MOBILIZATION OF PERIPHERAL-BLOODPROGENITOR CELLS (PBPC) IN ADVANCED BREAST-CANCER, Blood, 86(10), 1995, pp. 2301-2301
Authors:
SCHENKEIN DP
MILLER KB
SWEET M
ROSENBACH M
STADTMAUER E
CASSILETH P
COOPER B
LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL BOOD STEM-CELL (PBSC) TRANSPLANTATION AS INITIAL THERAPY FOR HIGH-RISK NON-HODSKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 86(10), 1995, pp. 3844-3844